Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abuzar Moradi Tuchayi

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 8, 2024
Impact of Posttreatment SPECT/CT on Patient Management During <sup>177</sup>Lu-PSMA-617 Radiopharmaceutical TherapySurekha Yadav, Blair Lowery, Abuzar Moradi Tuchayi, et al.
EJNMMI Research|April 7, 2025
Pre- or post-chemotherapy: effect on PSMA uptakeSurekha Yadav, Abuzar Moradi Tuchayi, Moein Moradpour, et al.
Frontiers in Oncology|July 12, 2024
Comparison of <sup>18</sup>F-DCFPyL and <sup>68</sup>Ga-PSMA-11 for <sup>177</sup>Lu-PSMA-617 therapy patient selectionSurekha Yadav, Sarasa T Kim, Abuzar Moradi Tuchayi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 14, 2024
Real-World Experience with <sup>177</sup>Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration ApprovalAbuzar Moradi Tuchayi, Surekha Yadav, Fei Jiang, et al.
Journal of the American College of Radiology : JACR|March 26, 2020
Novel Screening and Triage Strategy in Iran During Deadly Coronavirus Disease 2019 (COVID-19) Epidemic: Value of Humanitarian Teleconsultation ServiceAmir H Davarpanah, Arash Mahdavi, Ali Sabri, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2026
Prostate-Specific Membrane Antigen Radioligand Therapy in Patients with Aggressive-Variant Prostate CancerMoein Moradpour, Abuzar Moradi Tuchayi, Surekha Yadav, et al.
Clinical Imaging|April 3, 2022
Comparative effectiveness of pelvic arterial embolization versus laparotomy in adults with pelvic injuries: A National Trauma Data Bank analysisAbuzar Moradi Tuchayi, Nariman Nezami, Yuchen Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
PSMA PET/CT-Derived Indicators and Outcomes After [<sup>177</sup>Lu]Lu-PSMA-617: A Multicenter Retrospective Analysis from the U.S. Expanded-Access ProgramKoichiro Kimura, Vishnu Murthy, Andrew F Voter, et al.
JNCI Cancer Spectrum|October 9, 2025
Utility of metastasis-directed radiotherapy with and without hormonal therapy in management of oligometastatic prostate cancerWilliam S Chen, Abuzar Moradi Tuchayi, Ali Sabbagh, et al.
JCO Precision Oncology|April 25, 2024
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to <sup>177</sup>Lu-PSMA-617: A Retrospective Multicenter Cohort StudyRuben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 8, 2024
Impact of Posttreatment SPECT/CT on Patient Management During <sup>177</sup>Lu-PSMA-617 Radiopharmaceutical TherapySurekha Yadav, Blair Lowery, Abuzar Moradi Tuchayi, et al.
EJNMMI Research|April 7, 2025
Pre- or post-chemotherapy: effect on PSMA uptakeSurekha Yadav, Abuzar Moradi Tuchayi, Moein Moradpour, et al.
Frontiers in Oncology|July 12, 2024
Comparison of <sup>18</sup>F-DCFPyL and <sup>68</sup>Ga-PSMA-11 for <sup>177</sup>Lu-PSMA-617 therapy patient selectionSurekha Yadav, Sarasa T Kim, Abuzar Moradi Tuchayi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 14, 2024
Real-World Experience with <sup>177</sup>Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration ApprovalAbuzar Moradi Tuchayi, Surekha Yadav, Fei Jiang, et al.
Journal of the American College of Radiology : JACR|March 26, 2020
Novel Screening and Triage Strategy in Iran During Deadly Coronavirus Disease 2019 (COVID-19) Epidemic: Value of Humanitarian Teleconsultation ServiceAmir H Davarpanah, Arash Mahdavi, Ali Sabri, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2026
Prostate-Specific Membrane Antigen Radioligand Therapy in Patients with Aggressive-Variant Prostate CancerMoein Moradpour, Abuzar Moradi Tuchayi, Surekha Yadav, et al.
Clinical Imaging|April 3, 2022
Comparative effectiveness of pelvic arterial embolization versus laparotomy in adults with pelvic injuries: A National Trauma Data Bank analysisAbuzar Moradi Tuchayi, Nariman Nezami, Yuchen Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
PSMA PET/CT-Derived Indicators and Outcomes After [<sup>177</sup>Lu]Lu-PSMA-617: A Multicenter Retrospective Analysis from the U.S. Expanded-Access ProgramKoichiro Kimura, Vishnu Murthy, Andrew F Voter, et al.
JNCI Cancer Spectrum|October 9, 2025
Utility of metastasis-directed radiotherapy with and without hormonal therapy in management of oligometastatic prostate cancerWilliam S Chen, Abuzar Moradi Tuchayi, Ali Sabbagh, et al.
JCO Precision Oncology|April 25, 2024
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to <sup>177</sup>Lu-PSMA-617: A Retrospective Multicenter Cohort StudyRuben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi, et al.
Pageof 2